Publication | Closed Access

Insights into a class of natural eugenol and its optimized derivatives as potential tobacco mosaic virus helicase inhibitors by structure-based virtual screening

Optimized DerivativesNatural EugenolEngineeringSynthetic VirologyMedicineAntiviral Drug DevelopmentBiotechnologyMolecular BiologySynthetic BiologyVirologyGenetic EngineeringPharmacologyAntiviral CompoundStructure-based Virtual ScreeningDrug DiscoveryHigh-throughput Screening